Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviral Singh

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Clinical Nuclear Medicine|June 5, 2019
Complete Regression of Lung Metastases in a Patient With Metastatic Castration-Resistant Prostate Cancer Using 177Lu-PSMA Radioligand TherapyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Visceral Medicine|November 28, 2017
Theranostics of Neuroendocrine TumorsSze Ting Lee, Harshad R Kulkarni, Aviral Singh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2015
Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)Ameya D Puranik, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|October 31, 2019
Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide TherapyWenjia Zhu, Jingjing Zhang, Aviral Singh, et al.
Clinical Nuclear Medicine|September 5, 2018
Pregnancy and Delivery After PRRT Without SequelaeJingjing Zhang, Harshad R Kulkarni, Coline Lehmann, et al.
PET Clinics|June 4, 2017
Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in OncologyTheodosia Maina, Berthold A Nock, Harshad Kulkarni, et al.
Journal of the American Society for Mass Spectrometry|June 3, 2026
MetaDilutionR: An R Package for Data-Driven Determination of Optimal Plasma Dilution in Untargeted Metabolomics to Achieve Maximum Metabolite Coverage with ESI LinearityKeerthana Vinod Kumar, Aviral Singh, Sneha Rana, et al.
Nuclear Medicine Review. Central & Eastern Europe|June 23, 2006
The role of 18F-FDG PET in oncology: clinical and resource implicationsAdil Al-Nahhas, Zarni Win, Aviral Singh, et al.
Current Research in Toxicology|April 23, 2026
A novel non-invasive imaging technique for mapping microplastic accumulation and distribution in different organ systems of Indian major carp <i>Labeo rohita</i> (Ham. 1822)Sneha Siwach, Aviral Singh, Soumyadeep Paul, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2007
What can gallium-68 PET add to receptor and molecular imaging?Adil Al-Nahhas, Zarni Win, Teresa Szyszko, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Clinical Nuclear Medicine|June 5, 2019
Complete Regression of Lung Metastases in a Patient With Metastatic Castration-Resistant Prostate Cancer Using 177Lu-PSMA Radioligand TherapyJingjing Zhang, Harshad R Kulkarni, Aviral Singh, et al.
Visceral Medicine|November 28, 2017
Theranostics of Neuroendocrine TumorsSze Ting Lee, Harshad R Kulkarni, Aviral Singh, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 31, 2015
Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours)Ameya D Puranik, Harshad R Kulkarni, Aviral Singh, et al.
Clinical Nuclear Medicine|October 31, 2019
Metastatic Nasopharyngeal Carcinoma Treated With Intraarterial Combined With Intravenous Peptide Receptor Radionuclide TherapyWenjia Zhu, Jingjing Zhang, Aviral Singh, et al.
Clinical Nuclear Medicine|September 5, 2018
Pregnancy and Delivery After PRRT Without SequelaeJingjing Zhang, Harshad R Kulkarni, Coline Lehmann, et al.
PET Clinics|June 4, 2017
Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in OncologyTheodosia Maina, Berthold A Nock, Harshad Kulkarni, et al.
Journal of the American Society for Mass Spectrometry|June 3, 2026
MetaDilutionR: An R Package for Data-Driven Determination of Optimal Plasma Dilution in Untargeted Metabolomics to Achieve Maximum Metabolite Coverage with ESI LinearityKeerthana Vinod Kumar, Aviral Singh, Sneha Rana, et al.
Nuclear Medicine Review. Central & Eastern Europe|June 23, 2006
The role of 18F-FDG PET in oncology: clinical and resource implicationsAdil Al-Nahhas, Zarni Win, Aviral Singh, et al.
Current Research in Toxicology|April 23, 2026
A novel non-invasive imaging technique for mapping microplastic accumulation and distribution in different organ systems of Indian major carp <i>Labeo rohita</i> (Ham. 1822)Sneha Siwach, Aviral Singh, Soumyadeep Paul, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2007
What can gallium-68 PET add to receptor and molecular imaging?Adil Al-Nahhas, Zarni Win, Teresa Szyszko, et al.
Pageof 6